No-treatment control
Sponsors
Galderma R&D, Allergan, Nunaps Inc, AbbVie
Conditions
Healthy VolunteersHemianopsia, HomonymousIntermittent ExotropiaJawline DefinitionLip EnhancementNasolabial FoldsNose EnhancementTemple Hollowing
Phase 2
Phase 3
Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition
CompletedNCT03712137
Start: 2018-11-12End: 2021-01-26Updated: 2023-01-04
A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old
CompletedNCT04414397
Start: 2020-05-28End: 2022-10-17Updated: 2024-04-25
Phase 4
Unknown Phase
Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine for Improvement of Volume and Aesthetic Appearance of the Nose in Chinese Adults
CompletedNCT03430986
Start: 2018-02-02End: 2019-12-04Updated: 2020-12-30
Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults
CompletedNCT03519204
Start: 2016-01-28End: 2018-03-30Updated: 2019-08-06
Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke
CompletedNCT05525949
Start: 2022-10-19End: 2023-11-08Updated: 2023-11-13
Visual Perceptual Learning Based Digital Therapeutics for Stereopsis in Intermittent Exotropia
CompletedNCT06117813
Start: 2023-12-22End: 2025-07-16Updated: 2025-09-18